Quanterix (NASDAQ:QTRX – Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, March 6th. Analysts expect Quanterix to post earnings of ($0.27) per share and revenue of $34.93 million for the quarter.
Quanterix (NASDAQ:QTRX – Get Free Report) last released its quarterly earnings results on Monday, December 23rd. The company reported ($0.22) earnings per share (EPS) for the quarter. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. On average, analysts expect Quanterix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Quanterix Stock Up 6.1 %
NASDAQ:QTRX opened at $7.52 on Wednesday. The stock’s 50 day moving average price is $9.23 and its 200 day moving average price is $11.38. The company has a market capitalization of $289.70 million, a PE ratio of -7.09 and a beta of 1.33. Quanterix has a 52-week low of $6.80 and a 52-week high of $29.70.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on QTRX
About Quanterix
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Read More
- Five stocks we like better than Quanterix
- What is a Death Cross in Stocks?
- GitLab: Get In While It’s Down—Big Rebound Ahead
- What is a Stock Market Index and How Do You Use Them?
- Tesla Stock: Finding a Bottom May Take Time
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.